Researchers at the MRC Laboratory of Medical Sciences (LMS) and Imperial College London have identified an overworked cog in the cellular machinery of tumor cells that could be targeted by new ...

The gene-editing market is projected to grow to $30.8 billion by 2032, highlighting investment potential. CRISPR Therapeutics, co-founder by Charpentier, gains momentum with FDA-approved therapies.

Add Yahoo as a preferred source to see more of our stories on Google. Red Hot Chili Peppers reach a major milestone as Greatest Hits spends 500 weeks on the Official Albums chart, marking a first for ...

Apr. 7, 2026 A gene called KLF5 may be a key force behind the spread of pancreatic cancer—but not in the way scientists expected. Rather than mutating DNA, it rewires how genes are turned on and off, ...